Emergent BioSolutions
EBS
#7959
Rank
C$0.52 B
Marketcap
C$10.26
Share price
-3.00%
Change (1 day)
-1.84%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of March 2026 : C$0.80 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is C$0.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.78 B-17.74%
2024-12-31C$0.95 B-16.52%
2023-12-31C$1.14 B-40.19%
2022-12-31C$1.90 B77.98%
2021-12-31C$1.07 B-3.91%
2020-12-31C$1.11 B5.27%
2019-12-31C$1.05 B-2.11%
2018-12-31C$1.08 B6277.26%
2017-12-31C$16.97 M-95.29%
2016-12-31C$0.36 B5.19%
2015-12-31C$0.34 B17.58%
2014-12-31C$0.29 B341.34%
2013-12-31C$65.99 M5.73%
2012-12-31C$62.42 M3.22%
2011-12-31C$60.47 M27.57%
2010-12-31C$47.4 M-31.44%
2009-12-31C$69.14 M-0.55%
2008-12-31C$69.52 M20.3%
2007-12-31C$57.79 M16.06%
2006-12-31C$49.79 M259.13%
2005-12-31C$13.86 M-10.28%
2004-12-31C$15.45 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$89.84 B 11,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$69.24 B 8,462.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$35.57 B 4,299.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
C$0.46 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.75 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.68 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.83 B 2,847.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel